Cite
HARVARD Citation
Giordano, G. et al. (n.d.). 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). European journal of cancer. pp. S445-. [Online].